New Treatment for Those with Mild to Moderate COVID-19 A new treatment for those diagnosed with mild to moderate COVID-19 is being offered at Essentia in Duluth. February 9, 2021 NORTHLAND – A new treatment for those diagnosed with mild to moderate COVID-19 is being offered at Essentia in Duluth. The drug being used in this new antibody treatment at Essentia Health is called bamlanivimab, which mimics the immune system’s ability to fight off viruses like COVID. The aim of the treatment is to make sure that people don’t progress to more severe disease after getting COVID. “And so we are targeting patients with mild to moderate symptoms in hopes that we will be able to keep them out of the emergency department and hospitalization,’ said Stephanie Nixon, the antimicrobial stewardship program manager at Essentia Health.